The Latest Headlines at Riverton Roll
Texas Instruments (NASDAQ:TXN) Releases Q3 2021 Earnings Guidance
Texas Instruments (NASDAQ:TXN) updated its third quarter 2021 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $1.870-$2.130 for the period, compared to the Thomson Reuters consensus estimate... More of this article »
ABBC Coin (ABBC) Price Up 16% Over Last Week
ABBC Coin (CURRENCY:ABBC) traded down 0.4% against the U.S. dollar during the 24-hour period ending at 19:00 PM E.T. on July 28th. ABBC Coin has a total market capitalization of $186.87 million and $42.58 million worth of ABBC Coin... More of this article »
Brokerages Expect Gibraltar Industries, Inc. (NASDAQ:ROCK) Will Announce Earnings of $0.90 Per Share
Wall Street analysts expect that Gibraltar Industries, Inc. (NASDAQ:ROCK) will announce $0.90 earnings per share for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Gibraltar Industries’ earnings.... More of this article »
Alchemy Pay (ACH) Trading Up 98.3% Over Last 7 Days
Alchemy Pay (CURRENCY:ACH) traded 63.5% higher against the dollar during the one day period ending at 19:00 PM ET on July 28th. One Alchemy Pay coin can now be purchased for approximately $0.0030 or 0.00000007 BTC on major cryptocurrency... More of this article »
MIR COIN Trading Down 1.8% This Week (MIR)
MIR COIN (CURRENCY:MIR) traded 0.5% higher against the dollar during the one day period ending at 19:00 PM Eastern on July 28th. MIR COIN has a total market capitalization of $3.82 million and $81,255.00 worth of MIR COIN was traded... More of this article »
Omnitude Price Tops $0.0069 on Top Exchanges (ECOM)
Omnitude (CURRENCY:ECOM) traded 6.9% lower against the U.S. dollar during the one day period ending at 19:00 PM ET on July 28th. Over the last seven days, Omnitude has traded 4.3% lower against the U.S. dollar. Omnitude has a total... More of this article »
VBI Vaccines Inc. (NASDAQ:VBIV) Expected to Announce Earnings of -$0.08 Per Share
Equities analysts expect VBI Vaccines Inc. (NASDAQ:VBIV) to post earnings of ($0.08) per share for the current quarter, according to Zacks. Three analysts have provided estimates for VBI Vaccines’ earnings, with the highest EPS... More of this article »
Teladoc Health (NYSE:TDOC) Announces Quarterly Earnings Results
Teladoc Health (NYSE:TDOC) announced its quarterly earnings results on Tuesday. The health services provider reported ($0.86) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.59) by ($0.27),... More of this article »
Encompass Health (NYSE:EHC) Releases Quarterly Earnings Results, Beats Estimates By $0.19 EPS
Encompass Health (NYSE:EHC) issued its quarterly earnings data on Monday. The company reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.98 by $0.19, MarketWatch Earnings reports. Encompass... More of this article »
GDS Holdings Limited (NASDAQ:GDS) Receives $111.00 Consensus Target Price from Brokerages
GDS Holdings Limited (NASDAQ:GDS) has been assigned a consensus recommendation of “Buy” from the ten research firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with... More of this article »
Bitradio Price Reaches $0.0068 on Exchanges (BRO)
Bitradio (CURRENCY:BRO) traded 4.7% higher against the U.S. dollar during the twenty-four hour period ending at 19:00 PM E.T. on July 28th. In the last week, Bitradio has traded up 26% against the U.S. dollar. One Bitradio coin can... More of this article »
Jonathan Bourgoine Sells 1,250 Shares of Stamps.com Inc. (NASDAQ:STMP) Stock
Stamps.com Inc. (NASDAQ:STMP) CTO Jonathan Bourgoine sold 1,250 shares of the firm’s stock in a transaction that occurred on Monday, July 26th. The shares were sold at an average price of $325.33, for a total transaction of $406,662.50.... More of this article »
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Average Rating of “Buy” by Brokerages
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) has been assigned a consensus rating of “Buy” from the nine research firms that are presently covering the firm, MarketBeat Ratings reports. Seven analysts have rated the stock with... More of this article »